About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: To find a complete list of Publications, please see listing here.

 

Found 9 results
Filters: Author is Holtan, Shernan G  [Clear All Filters]
2023
J. Bolaños-Meade, Hamadani, M., Wu, J., Malki, M. M. Al, Martens, M. J., Runaas, L., Elmariah, H., Rezvani, A. R., Gooptu, M., Larkin, K. T., Shaffer, B. C., Jurdi, N. El, Loren, A. W., Solh, M., Hall, A. C., Alousi, A. M., Jamy, O. H., Perales, M. - A., Yao, J. M., Applegate, K., Bhatt, A. S., Kean, L. S., Efebera, Y. A., Reshef, R., Clark, W., DiFronzo, N. L., Leifer, E., Horowitz, M. M., Jones, R. J., and Holtan, S. G., “Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.”, N Engl J Med, vol. 388, no. 25, pp. 2338-2348, 2023.
2022
S. Vasu, Holtan, S. G., Shimamura, A., Burnworth, T., Whisenton, S., Adams, S., Nuechterlein, B., Mortier, N., Foster, J., DiFronzo, N., Horowitz, M., Rizzo, D., and Foley, A., “Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force.”, Transplant Cell Ther, vol. 29, no. 1, pp. 5-9, 2022.
2020
L. F. Newell, DeFor, T. E., Cutler, C., Verneris, M. R., Blazar, B. R., Miller, J. S., Antin, J. H., Howard, A., Wu, J., MacMillan, M. L., Panoskaltsis-Mortari, A., Weisdorf, D. J., and Holtan, S. G., “Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.”, Biol Blood Marrow Transplant, vol. 26, no. 3, pp. 606-611, 2020.
J. Pidala, Hamadani, M., Dawson, P., Martens, M., Alousi, A. M., Jagasia, M., Efebera, Y. A., Chhabra, S., Pusic, I., Holtan, S. G., Ferrara, J. L. M., Levine, J. E., Mielcarek, M., Anasetti, C., Antin, J. H., Bolaños-Meade, J., Howard, A., Logan, B. R., Leifer, E. S., Pritchard, T. S., Horowitz, M. M., and MacMillan, M. L., “Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.”, Blood, vol. 135, no. 2, pp. 97-107, 2020.
2019
J. Bolaños-Meade, Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadhimi, Z., Alousi, A. M., Antin, J. H., Arai, S., Bickett, K., Bin Chen, Y. -, Damon, L. E., Efebera, Y. A., Geller, N. L., Giralt, S. A., Hari, P., Holtan, S. G., Horowitz, M. M., Jacobsohn, D. A., Jones, R. J., Liesveld, J. L., Logan, B. R., MacMillan, M. L., Mielcarek, M., Noel, P., Pidala, J., Porter, D. L., Pusic, I., Sobecks, R., Solomon, S. R., Weisdorf, D. J., Wu, J., Pasquini, M. C., and Koreth, J., “Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with ”, Lancet Haematol, vol. 6, no. 3, pp. e132-e143, 2019.
2018
S. G. Holtan, DeFor, T. E., Panoskaltsis-Mortari, A., Khera, N., Levine, J. E., Flowers, M. E. D., Lee, S. J., Inamoto, Y., Chen, G. L., Mayer, S., Arora, M., Palmer, J., Cutler, C. S., Arai, S., Lazaryan, A., Newell, L. F., Jagasia, M. H., Pusic, I., Wood, W. A., Renteria, A. S., Yanik, G., Hogan, W. J., Hexner, E., Ayuk, F., Holler, E., Bunworasate, U., Efebera, Y. A., Ferrara, J. L. M., Pidala, J., Howard, A., Wu, J., Bolaños-Meade, J., Ho, V., Alousi, A., Blazar, B. R., Weisdorf, D. J., and MacMillan, M. L., “Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.”, Blood Adv, vol. 2, no. 15, pp. 1882-1888, 2018.
A. Rashidi, Wangjam, T., Bhatt, A. S., Weisdorf, D. J., and Holtan, S. G., “Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers.”, Am J Hematol, vol. 93, no. 11, pp. E348-E350, 2018.
2015
S. G. Holtan, Verneris, M. R., Schultz, K. R., Newell, L. F., Meyers, G., He, F., DeFor, T. E., Vercellotti, G. M., Slungaard, A., MacMillan, M. L., Cooley, S. A., Blazar, B. R., Panoskaltsis-Mortari, A., and Weisdorf, D. J., “Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.”, Biol Blood Marrow Transplant, vol. 21, no. 6, pp. 1029-36, 2015.
M. L. MacMillan, Robin, M., Harris, A. C., DeFor, T. E., Martin, P. J., Alousi, A., Ho, V. T., Bolaños-Meade, J., Ferrara, J. L. M., Jones, R., Arora, M., Blazar, B. R., Holtan, S. G., Jacobsohn, D., Pasquini, M., Socie, G., Antin, J. H., Levine, J. E., and Weisdorf, D. J., “A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.”, Biol Blood Marrow Transplant, vol. 21, no. 4, pp. 761-7, 2015.